China Universal Asset Management Company’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Buy |
16,813
+255
| +2% | +$561 | ﹤0.01% | 436 |
|
|
2025
Q1 | $19.2K | Sell |
16,558
-945
| -5% | -$1.1K | ﹤0.01% | 457 |
|
|
2024
Q4 | $22.2K | Buy |
17,503
+1,640
| +10% | +$2.08K | ﹤0.01% | 482 |
|
|
2024
Q3 | $54.1K | Buy |
15,863
+6,202
| +64% | +$21.1K | 0.01% | 383 |
|
|
2024
Q2 | $45.1K | Sell |
9,661
-6,052
| -39% | -$28.3K | 0.01% | 365 |
|
|
2024
Q1 | $117K | Buy |
15,713
+6,263
| +66% | +$46.5K | 0.01% | 357 |
|
|
2023
Q4 | $95.7K | Buy |
9,450
+7,355
| +351% | +$74.5K | 0.02% | 285 |
|
|
2023
Q3 | $16.3K | Buy |
2,095
+1,190
| +131% | +$9.28K | ﹤0.01% | 312 |
|
|
2023
Q2 | $7.45K | Sell |
905
-30
| -3% | -$247 | ﹤0.01% | 337 |
|
|
2023
Q1 | $6.78K | Buy |
935
+237
| +34% | +$1.72K | ﹤0.01% | 339 |
|
|
2022
Q4 | $6.19K | Buy |
698
+54
| +8% | +$479 | ﹤0.01% | 272 |
|
|
2022
Q3 | $8K | Buy |
+644
| New | +$8K | ﹤0.01% | 223 |
|